| 5.93 -0.2 (-3.26%) | 04-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.96  |
1-year : | 8.72 |
| Resists | First : | 6.82 |
Second : | 7.46 |
| Pivot price | 6.53 |
|||
| Supports | First : | 5.76 |
Second : | 4.8 |
| MAs | MA(5) : | 6.27 |
MA(20) : | 6.47 |
| MA(100) : | 10.45 |
MA(250) : | 13.14 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 12 |
D(3) : | 21.8 |
| RSI | RSI(14): 36 |
|||
| 52-week | High : | 22.25 | Low : | 5.53 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ OPRX ] has closed above bottom band by 2.4%. Bollinger Bands are 56.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.14 - 6.2 | 6.2 - 6.23 |
| Low: | 5.65 - 5.72 | 5.72 - 5.77 |
| Close: | 5.84 - 5.97 | 5.97 - 6.04 |
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
Sun, 12 Apr 2026
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
Sat, 11 Apr 2026
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
Wed, 08 Apr 2026
OptimizeRx adds Microsoft Health exec to board of directors - Investing.com
Wed, 08 Apr 2026
Microsoft health leader joins OptimizeRx (OPRX) board as independent director - Stock Titan
Wed, 08 Apr 2026
OptimizeRx Appoints Mary Varghese Presti to Board of Directors - GlobeNewswire
Wed, 01 Apr 2026
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 19 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 15.4 (%) |
| Held by Institutions | 74.3 (%) |
| Shares Short | 1,590 (K) |
| Shares Short P.Month | 1,670 (K) |
| EPS | 0.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.84 |
| Profit Margin | 4.6 % |
| Operating Margin | 27.7 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 4.1 % |
| Qtrly Rev. Growth | -0.3 % |
| Gross Profit (p.s.) | 3.92 |
| Sales Per Share | 5.83 |
| EBITDA (p.s.) | 0.87 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 19 (M) |
| Levered Free Cash Flow | 16 (M) |
| PE Ratio | 21.96 |
| PEG Ratio | 0 |
| Price to Book value | 0.86 |
| Price to Sales | 1.01 |
| Price to Cash Flow | 5.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|